Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 10/2019

Ausgabe 10/2019

Inhaltsverzeichnis ( 16 Artikel )

07.09.2019 | Original Article | Ausgabe 10/2019 Open Access

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients

Benoit Milcent, Nathalie Josseaume, Quentin Riller, Ilenia Giglioli, Emilia Rabia, Claire Deligne, Jean-Baptiste Latouche, Mohamad Hamieh, Alexandre Couture, Olivier Toutirais, Yu-Chun Lone, Raphaël Jeger-Madiot, Stéphanie Graff-Dubois, Sandy Amorim, Pascale Loiseau, Antoine Toubert, Pauline Brice, Catherine Thieblemont, Jean-Luc Teillaud, Sophie Sibéril

11.09.2019 | Original Article | Ausgabe 10/2019

Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression

Vasiliki Siozopoulou, Elly Marcq, Julie Jacobs, Karen Zwaenepoel, Christophe Hermans, Jantine Brauns, Siegrid Pauwels, Clément Huysentruyt, Martin Lammens, Johan Somville, Evelien Smits, Patrick Pauwels

12.09.2019 | Original Article | Ausgabe 10/2019

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

Estefanía Paula Juliá, Pablo Mandó, Manglio Miguel Rizzo, Gerardo Rubén Cueto, Florencia Tsou, Romina Luca, Carmen Pupareli, Alicia Inés Bravo, Walter Astorino, José Mordoh, Claudio Martín, Estrella Mariel Levy

14.09.2019 | Original Article | Ausgabe 10/2019

ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy

Masoud Sotoudeh, Ramin Shakeri, Sanford M. Dawsey, Bahareh Sharififard, Naser Ahmadbeigi, Mahmood Naderi

17.09.2019 | Original Article | Ausgabe 10/2019 Open Access

Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells

Yuji Tomita, Eri Watanabe, Masumi Shimizu, Yasuyuki Negishi, Yukihiro Kondo, Hidemi Takahashi

23.09.2019 | Original Article | Ausgabe 10/2019 Open Access

The BRCA2 mutation status shapes the immune phenotype of prostate cancer

Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leichsenring, Fabian Stögbauer, Josh Haimes, Skyler Mishkin, Brian Kudlow, Adam Kaczorowski, Stefanie Zschäbitz, Anna-Lena Volckmar, Holger Sültmann, Dirk Jäger, Anette Duensing, Peter Schirmacher, Markus Hohenfellner, Carsten Grüllich, Albrecht Stenzinger, Stefan Duensing

24.09.2019 | Original Article | Ausgabe 10/2019

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

Nicholas Osborne, Rebecca Sundseth, Julian Burks, Hong Cao, Xunxian Liu, Alexander H. Kroemer, Lynda Sutton, Allen Cato, Jill P. Smith

27.09.2019 | Original Article | Ausgabe 10/2019

PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor

Akiko Fujimura, Kazunori Nakayama, Akira Imaizumi, Makoto Kawamoto, Yasuhiro Oyama, Shu Ichimiya, Masayo Umebayashi, Norihiro Koya, Takashi Morisaki, Takashi Nakagawa, Hideya Onishi

12.10.2019 | Original Article | Ausgabe 10/2019

Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy

Chris D. Zahm, Laura E. Johnson, Douglas G. McNeel

23.03.2019 | Focussed Research Review | Ausgabe 10/2019

The role of immune infiltrates as prognostic biomarkers in patients with breast cancer

Constantin N. Baxevanis, Michael Sofopoulos, Sotirios P. Fortis, Sonia A. Perez

03.04.2019 | Focussed Research Review | Ausgabe 10/2019 Open Access

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

Jossie Rotman, Bas D. Koster, Ekaterina S. Jordanova, A. Marijne Heeren, Tanja D. de Gruijl

03.08.2019 | Focussed Research Review | Ausgabe 10/2019

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy

Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, Karthikeyan Subbarayan, Chiara Massa, Sandy Tretbar, Anja Mueller, Diana Handke, Katharina Biehl, Jürgen Bukur, Marco Donia, Ofer Mandelboim, Barbara Seliger

21.09.2019 | Focussed Research Review | Ausgabe 10/2019

T cell engineering for adoptive T cell therapy: safety and receptor avidity

Elvira D’Ippolito, Kilian Schober, Magdalena Nauerth, Dirk H. Busch

21.09.2019 | Focussed Research Review | Ausgabe 10/2019 Open Access

Conventional CARs versus modular CARs

Anja Feldmann, Claudia Arndt, Stefanie Koristka, Nicole Berndt, Ralf Bergmann, Michael P. Bachmann

13.10.2019 | Focussed Research Review | Ausgabe 10/2019

Natural killer cells control metastasis via structural editing of primary tumors in mice

Batya Isaacson, Ofer Mandelboim

04.04.2019 | Meeting Report | Ausgabe 10/2019

“Tumor Immunology Meets Oncology (TIMO) XIV”, May 24–26th 2018, Halle/Saale, Germany

André Steven, Barbara Seliger

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise